How is India streamlining the pharma sector? | Explained thehindu.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from thehindu.com Daily Mail and Mail on Sunday newspapers.
The government has expanded a committee to include more industry representation for reviewing drug and medical device pricing reforms. This move aims to ensure better availability of medicines and devices, while also providing incentives for industry growth and export sustainability. The committee will engage with industry experts and associations to evaluate pricing and availability issues. Ultimately, the government will make the final decisions, with the committee focusing on balancing pricing and availability of essential medicines and designing a price moderation framework for medical devices.
Various drugs manufactured by listed players like Sun Pharmaceuticals, Alkem Laboratories, Cipla Ltd, Mankind Pharma, Lupin Ltda and Torrent Pharma are included in the list.
FOPE said that the manufactures follow the rules as laid down in the DPCO, 2013. At the same time, manufacturers look to NPPA to fix the price expeditiously and as per the NPPA s defined timelines for various provisions under DPCO including disposal of Form-1 application.
16th edition of CPHI & PMEC India Expo to be held from November 28-30; over 1,500 leading pharma exhibitors to participate financialexpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from financialexpress.com Daily Mail and Mail on Sunday newspapers.